Fibromyalgia

Table of Contents

What Is Fibromyalgia?

Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness throughout the body. It affects an estimated 2-4% of the population and is classified as a central sensitization syndrome, meaning the central nervous system amplifies pain signals, causing the brain to perceive pain more intensely than normal.

Unlike inflammatory arthritis or autoimmune conditions, fibromyalgia does not cause visible tissue damage or inflammation detectable on standard lab tests. This has historically led to misunderstanding and underdiagnosis. However, modern research confirms that fibromyalgia involves measurable changes in pain processing, neurotransmitter levels, and brain function.

From a naturopathic perspective, fibromyalgia is viewed as a multisystem disorder involving dysfunction of the nervous system, immune system, hormonal regulation, and mitochondrial energy production. Addressing the root causes rather than merely suppressing symptoms is central to effective management.

Diagnostic Criteria

Diagnosis of fibromyalgia has evolved significantly over the decades. The original 1990 American College of Rheumatology (ACR) criteria required identification of at least 11 of 18 specific tender points upon physical examination. While tender point exams are still used clinically, updated criteria have broadened the diagnostic framework.

The 2010/2011 revised ACR criteria use two key measures:

A fibromyalgia diagnosis is made when the WPI is 7 or greater and SSS is 5 or greater, or the WPI is 3-6 and SSS is 9 or greater. Symptoms must have been present for at least 3 months, and the patient must not have another disorder that would otherwise explain the pain.

Symptoms Beyond Pain

While widespread chronic pain is the hallmark of fibromyalgia, the condition manifests as a complex constellation of symptoms affecting nearly every body system:

Causes and Theories

The exact cause of fibromyalgia remains under investigation, but several well-supported theories have emerged:

Central Sensitization

The most widely accepted mechanism. In fibromyalgia, the central nervous system becomes hypersensitive to pain signals. Neuroimaging studies demonstrate increased activation in pain-processing brain regions (anterior cingulate cortex, insular cortex) in response to stimuli that healthy individuals would not perceive as painful. Elevated levels of substance P (a pain neurotransmitter) in cerebrospinal fluid have been consistently documented.

Mitochondrial Dysfunction

Research shows that fibromyalgia patients often exhibit impaired mitochondrial function, leading to reduced cellular energy (ATP) production. This may explain the characteristic fatigue, muscle pain, and exercise intolerance. Coenzyme Q10 levels are frequently found to be low in fibromyalgia patients.

Small Fiber Neuropathy

Skin biopsy studies have revealed reduced density of small nerve fibers in the skin of fibromyalgia patients. This objective finding suggests that at least some fibromyalgia pain originates from actual peripheral nerve damage, challenging the notion that the condition is purely central.

Gut-Brain Axis Dysfunction

Emerging research highlights alterations in the gut microbiome of fibromyalgia patients. Dysbiosis (imbalanced gut flora) may contribute to systemic inflammation, altered neurotransmitter production (the gut produces approximately 90% of the body's serotonin), and immune dysregulation. Increased intestinal permeability ("leaky gut") has also been observed.

Neuroendocrine Disruption

Abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis, reduced growth hormone secretion, and altered cortisol patterns are commonly found. These disruptions affect pain perception, sleep quality, and tissue repair.

Risk Factors

Conventional Treatments

Three medications are FDA-approved specifically for fibromyalgia:

Other commonly prescribed medications include low-dose tricyclic antidepressants (amitriptyline), muscle relaxants (cyclobenzaprine), and tramadol. Opioids are generally not recommended due to lack of efficacy and risk of hyperalgesia (paradoxically increased pain sensitivity).

Natural and Naturopathic Approaches

A naturopathic approach to fibromyalgia focuses on restoring mitochondrial function, reducing central sensitization, optimizing neurotransmitter balance, and supporting overall cellular health:

Magnesium

Magnesium deficiency is common in fibromyalgia and contributes to muscle pain, spasms, sleep disturbance, and nerve excitability. Magnesium glycinate or magnesium malate (300-600 mg daily) are preferred forms. Magnesium malate in particular provides malic acid, which supports mitochondrial ATP production.

Coenzyme Q10 (CoQ10)

Studies have shown significantly reduced CoQ10 levels in fibromyalgia patients. Supplementation (200-300 mg daily of ubiquinol form) may improve pain, fatigue, and morning tiredness by supporting mitochondrial energy production and reducing oxidative stress.

D-Ribose

A naturally occurring sugar that is a building block of ATP. Clinical trials have shown that D-ribose supplementation (5 grams three times daily) can significantly improve energy, sleep, mental clarity, and pain intensity in fibromyalgia patients.

SAMe (S-Adenosyl-L-Methionine)

SAMe is involved in methylation reactions, neurotransmitter synthesis, and cartilage repair. Studies show it can reduce pain, fatigue, and depression in fibromyalgia. Typical dosing is 400-800 mg daily on an empty stomach.

5-HTP (5-Hydroxytryptophan)

A direct precursor to serotonin that may help with pain, sleep, anxiety, and depression. Dosing typically ranges from 100-300 mg daily. Do not combine with SSRI or SNRI medications due to risk of serotonin syndrome.

Vitamin D

Vitamin D deficiency is highly prevalent in fibromyalgia patients and is associated with increased pain severity. Testing and correcting deficiency (targeting serum levels of 50-70 ng/mL) with vitamin D3 supplementation can reduce pain and improve function.

Omega-3 Fatty Acids

Fish oil (2-4 grams daily of combined EPA/DHA) provides anti-inflammatory and neuroprotective effects. Omega-3s support healthy cell membrane function, reduce pro-inflammatory cytokines, and may improve nerve conduction.

Low-Dose Naltrexone (LDN)

An emerging treatment showing significant promise. At low doses (1.5-4.5 mg nightly), naltrexone modulates the immune system by temporarily blocking opioid receptors and reducing microglial cell activation in the brain. Multiple studies have demonstrated reductions in pain severity of approximately 30%. LDN requires a prescription and is typically obtained through compounding pharmacies.

Elimination Diet and Dietary Triggers

Dietary modification is a powerful and often underutilized tool in fibromyalgia management. Many patients report significant symptom improvement when specific triggers are removed:

A structured elimination diet lasting 4-6 weeks, followed by systematic reintroduction of one food group at a time, is the gold standard for identifying individual dietary triggers. An anti-inflammatory diet rich in vegetables, omega-3 fatty acids, berries, and whole foods forms the ideal baseline.

Exercise and Movement Therapy

Regular physical activity is one of the most well-supported interventions for fibromyalgia, yet it must be approached with care to avoid symptom flares:

The key principle is "start low and go slow." Overexertion triggers post-exertional malaise (symptom flares lasting days). Patients should exercise at 40-60% of their perceived capacity and increase duration and intensity no more than 10% per week.

Sleep Optimization

Non-restorative sleep is both a symptom and a perpetuating factor in fibromyalgia. Improving sleep quality can significantly reduce pain sensitivity and fatigue:

Stress Management

Chronic stress perpetuates central sensitization and HPA axis dysfunction. Effective stress management is not optional but essential in fibromyalgia treatment:

Important Cautions

Back to Table of Contents